AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Study on the Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in People Aged 50 to 70 Years Old

RecruitingPhase 2Ages 50 Years - 70 YearsAllRenJi Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Project Name: Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in People Aged 50 to 70: A Prospective, Multicenter, Randomized Controlled Clinical Trial The main purpose of the study is to investigate the effectiveness and safety of sodium phosphate powder for intestinal preparation in people aged 50 to 70. Secondary objective: To study the tolerance of sodium phosphate powder for intestinal preparation in the population aged 50 to 70 years and its impact on The impact of lesion detection. A prospective multicenter intervention randomized controlled clinical study of research design The total number of cases is 362 in the group leader center, with a total of 8 participating centers each having 44 cases. Treatment plan: Sodium phosphate powder group or Fujingqing group Main efficacy evaluation indicators: The effective rate of intestinal preparation, that is,

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age 50 to 70 years old, gender unlimited 2. No contraindications for colonoscopy examination, planned to undergo colonoscopy examination in the near future 3. Agree to participate in this study Exclusion Criteria: 1. Patients with a history of colorectal surgery (resection of malignant tumors, resection of rectal perforation, etc.) 2. Electrolyte disorders and hemodialysis patients 3. Patients with active lower gastrointestinal bleeding 4. Patients with abnormal coagulation function 5. Concomitant severe primary diseases such as lung, liver, kidney, and hematopoietic system, liver function ALT AST exceeds the upper limit of the reference value by 1.5 times, or Cr exceeds the upper limit of the reference value 6. Merge other diseases that may affect the efficacy judgment or pose a significant risk, such as acute inflammatory bowel disease, colon cancer, intussusception, volvulus, intestinal obstruction, peritonitis, ascites, stubborn constipation, etc 7. Patients with mental illness and severe neurosis 8. Patients known to have allergies to the investigational or control drugs 9. Participated in other clinical researchers within one month 10. Researchers believe that there are other situations that are not suitable for inclusion, and patients are unwilling to be included in the study
๐Ÿ’Š

What it tests

  • Sodium phosphate powder
  • Polyethylene glycol electrolyte dispersion
๐Ÿ“

Where

1 site
Shanghai Jiaotong University School of Medicine, Renji Hospital
Shanghai, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy